Your browser doesn't support javascript.
loading
Slit-independent guidance of longitudinal axons by Drosophila Robo3.
Carranza, Abigail; Howard, LaFreda J; Brown, Haley E; Ametepe, Ayawovi Selom; Evans, Timothy A.
Afiliación
  • Carranza A; Department of Biological Sciences, University of Arkansas, Fayetteville, AR 72701.
  • Howard LJ; Current Address: Texas A&M University School of Medicine, Bryan, TX 77807.
  • Brown HE; Department of Biological Sciences, University of Arkansas, Fayetteville, AR 72701.
  • Ametepe AS; Current Address: NAVA PBC, Washington, DC 20005.
  • Evans TA; Department of Biological Sciences, University of Arkansas, Fayetteville, AR 72701.
bioRxiv ; 2023 May 09.
Article en En | MEDLINE | ID: mdl-37214810
Drosophila Robo3 is a member of the evolutionarily conserved Roundabout (Robo) receptor family and one of three Drosophila Robo paralogs. During embryonic ventral nerve cord development, Robo3 does not participate in canonical Slit-dependent midline repulsion, but instead regulates the formation of longitudinal axon pathways at specific positions along the medial-lateral axis. Longitudinal axon guidance by Robo3 is hypothesized to be Slit dependent, but this has not been directly tested. Here we create a series of Robo3 variants in which the N-terminal Ig1 domain is deleted or modified, in order to characterize the functional importance of Ig1 and Slit binding for Robo3's axon guidance activity. We show that Robo3 requires its Ig1 domain for interaction with Slit and for proper axonal localization in embryonic neurons, but deleting Ig1 from Robo3 only partially disrupts longitudinal pathway formation. Robo3 variants with modified Ig1 domains that cannot bind Slit retain proper localization and fully rescue longitudinal axon guidance. Our results indicate that Robo3 guides longitudinal axons independently of Slit, and that sequences both within and outside of Ig1 contribute to this Slit-independent activity.

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: BioRxiv Año: 2023 Tipo del documento: Article